DiaMedica Therapeutics (DMAC) Short Interest Ratio & Short Volume $4.12 -0.10 (-2.37%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$4.10 -0.02 (-0.49%) As of 08/1/2025 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DiaMedica Therapeutics Short Interest DataDiaMedica Therapeutics (DMAC) has a short interest of 2.41 million shares. This marks a 13.68% increase in short interest from the previous month. The short interest ratio (days to cover) is 10.5, indicating that it would take 10.5 days of the average trading volume of 392,943 shares to cover all short positions.Current Short Interest2,410,000 sharesPrevious Short Interest2,120,000 sharesChange Vs. Previous Month+13.68%Dollar Volume Sold Short$10.36 millionShort Interest Ratio10.5 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares42,880,000 sharesPercentage of Shares Shorted5.62%Today's Trading Volume203,997 sharesAverage Trading Volume392,943 sharesToday's Volume Vs. Average52% Short Selling DiaMedica Therapeutics? Sign up to receive the latest short interest report for DiaMedica Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartDMAC Short Interest Over TimeDMAC Days to Cover Over TimeDMAC Percentage of Float Shorted Over Time DiaMedica Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20252,410,000 shares $10.36 million +13.7%N/A10.5 $4.30 6/30/20252,120,000 shares $8.27 million +72.4%5.3%12.6 $3.90 6/15/20251,230,000 shares $4.49 million +11.8%3.1%11.2 $3.65 5/31/20251,100,000 shares $4.51 million +28.4%2.8%11.1 $4.10 5/15/2025856,900 shares $3.49 million +38.3%2.2%9.1 $4.07 4/30/2025619,700 shares $2.57 million +66.9%N/A6.8 $4.15 4/15/2025371,400 shares $1.30 million +1.4%0.9%4.3 $3.51 3/31/2025366,400 shares $1.39 million +38.7%0.9%4.1 $3.79 3/15/2025264,200 shares $1.52 million +4.2%0.7%3 $5.77 2/28/2025253,500 shares $1.66 million +9.1%0.6%2.8 $6.53 Get the Latest News and Ratings for DMAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/2025232,300 shares $1.46 million +21.1%0.6%2 $6.29 1/31/2025191,900 shares $1.11 million -8.4%N/A1.9 $5.76 1/15/2025209,500 shares $1.13 million -6.0%N/A2.1 $5.38 12/31/2024222,800 shares $1.21 million +14.5%N/A2.4 $5.43 12/15/2024194,600 shares $1.05 million +28.5%N/A2.2 $5.38 11/30/2024151,500 shares $857.49 thousand -12.2%N/A1.8 $5.66 11/15/2024172,500 shares $691.73 thousand -1.8%N/A2.4 $4.01 10/31/2024175,600 shares $767.37 thousand -4.2%N/A3.6 $4.37 10/15/2024183,300 shares $815.69 thousand +20.4%N/A3.5 $4.45 9/30/2024152,300 shares $638.14 thousand +10.0%N/A2.8 $4.19 9/15/2024138,400 shares $622.80 thousand -0.4%N/A1.9 $4.50 8/31/2024139,000 shares $546.27 thousand -2.1%N/A2.1 $3.93 8/15/2024142,000 shares $498.42 thousand -1.5%N/A2.3 $3.51 7/31/2024144,200 shares $472.98 thousand -17.0%N/A2.4 $3.28 7/15/2024173,700 shares $621.85 thousand +10.8%N/A3 $3.58 6/30/2024156,800 shares $462.56 thousand +22.1%N/A2.7 $2.95 6/15/2024128,400 shares $308.16 thousand -1.9%N/A3.5 $2.40 5/31/2024130,900 shares $379.61 thousand +1.8%N/A3.5 $2.90 5/15/2024128,600 shares $387.09 thousand -29.3%N/A3.3 $3.01 4/30/2024182,000 shares $469.56 thousand +3.8%N/A4.3 $2.58 4/15/2024175,400 shares $419.21 thousand -13.3%N/A4.4 $2.39 3/31/2024202,200 shares $560.09 thousand -4.9%N/A4.8 $2.77 3/15/2024212,600 shares $644.18 thousand +8.3%N/A5 $3.03 2/29/2024196,300 shares $588.90 thousand +3.7%N/A4.7 $3.00 2/15/2024189,300 shares $567.90 thousand -3.3%N/A4.4 $3.00 1/31/2024195,700 shares $551.87 thousand -3.1%N/A4 $2.82 1/15/2024202,000 shares $603.98 thousand +7.0%N/A4 $2.99 12/31/2023188,800 shares $536.19 thousand -2.2%N/A3.8 $2.84 12/15/2023193,100 shares $531.03 thousand +5.4%N/A3.7 $2.75 11/30/2023183,300 shares $447.25 thousand -24.9%N/A3.1 $2.44Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.Click here to see why Tesla's about to prove everyone wrong... again. 11/15/2023244,200 shares $598.29 thousand 0.0%N/A4 $2.45 10/31/2023244,300 shares $532.57 thousand +11.5%N/A4 $2.18 10/15/2023219,100 shares $449.16 thousand -1.1%N/A2.9 $2.05 9/30/2023221,500 shares $571.47 thousand +0.7%N/A2.3 $2.58 9/15/2023219,900 shares $712.48 thousand -0.8%N/A1.8 $3.24 8/31/2023221,700 shares $654.02 thousand -9.4%N/A1.5 $2.95 8/15/2023244,600 shares $725.24 thousand -10.6%N/A1.5 $2.97 7/31/2023273,500 shares $924.43 thousand -65.7%N/A1.6 $3.38 7/15/2023796,100 shares $3.01 million +11.6%4.5%5.4 $3.78 6/30/2023713,600 shares $3.08 million +910.8%4.0%5.4 $4.32 6/15/202370,600 shares $224.51 thousand +7.1%0.4%0.7 $3.18 5/31/202365,900 shares $179.91 thousand -21.2%0.4%1.1 $2.73 5/15/202383,600 shares $166.20 thousand -9.0%0.5%1.9 $1.99 4/30/202391,900 shares $149.80 thousand -5.7%0.5%3.4 $1.63 4/15/202397,400 shares $155.84 thousand +6.5%0.6%3.4 $1.60 3/31/202391,500 shares $140.00 thousand +55.6%0.5%2.9 $1.53 3/15/202358,800 shares $104.66 thousand +44.8%0.4%1.5 $1.78 2/28/202340,600 shares $70.24 thousand -1.7%0.3%0.7 $1.73 2/15/202341,300 shares $62.36 thousand +22.6%0.3%0.7 $1.51 1/31/202333,700 shares $45.50 thousand -57.8%0.2%0.5 $1.35 1/15/202379,800 shares $130.87 thousand -6.5%0.5%1.2 $1.64 12/30/202285,300 shares $134.78 thousand +113.8%0.5%1.3 $1.58 12/15/202239,900 shares $60.25 thousand -7.0%0.2%0.6 $1.51 11/30/202242,900 shares $51.05 thousand +24.4%0.2%0.7 $1.19 11/15/202234,500 shares $39.33 thousand -35.0%0.2%0.6 $1.14 10/31/202253,100 shares $62.66 thousand -47.5%0.3%0.9 $1.18 10/15/2022101,200 shares $153.82 thousand +245.4%0.6%1.9 $1.52 9/30/202229,300 shares $36.33 thousand -61.7%0.2%0.4 $1.24 9/15/202276,500 shares $110.93 thousand +153.3%0.4%0.5 $1.45 8/31/202230,200 shares $53.45 thousand -43.6%0.2%0.2 $1.77 8/15/202253,500 shares $96.84 thousand -0.2%0.3%0.4 $1.81 7/31/202253,600 shares $88.44 thousand +10.7%0.3%0.4 $1.65 7/15/202248,400 shares $61.95 thousand -8.2%0.3%0.4 $1.28 6/30/202252,700 shares $106.45 thousand +5.0%0.3%0.4 $2.02 6/15/202250,200 shares $110.44 thousand -1.6%0.3%1.1 $2.20 5/31/202251,000 shares $123.93 thousand -50.3%N/A1.2 $2.43 5/15/2022102,700 shares $250.59 thousand +85.4%N/A2.3 $2.44 4/30/202255,400 shares $128.53 thousand +62.5%N/A1.2 $2.32 4/15/202234,100 shares $79.11 thousand +5.9%N/A0.6 $2.32 3/31/202232,200 shares $80.50 thousand -45.8%N/A0.5 $2.50 3/15/202259,400 shares $136.62 thousand -26.0%N/A0.7 $2.30 2/28/202280,300 shares $211.19 thousand -23.5%N/A0.7 $2.63 2/15/2022104,900 shares $325.19 thousand +21.6%N/A0.9 $3.10 1/31/202286,300 shares $223.52 thousand +14.9%0.5%0.6 $2.59 1/15/202275,100 shares $253.84 thousand +22.1%0.4%0.4 $3.38 12/31/202161,500 shares $229.40 thousand -22.5%0.3%0.4 $3.73 12/15/202179,300 shares $307.68 thousand +55.8%0.4%0.4 $3.88 11/30/202150,900 shares $190.37 thousand -26.9%0.3%0.3 $3.74 11/15/202169,600 shares $280.49 thousand -21.5%0.4%0.3 $4.03 10/29/202188,700 shares $350.37 thousand -7.9%0.6%0.4 $3.95Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.Click here to see why Tesla's about to prove everyone wrong... again. 10/15/202196,300 shares $394.83 thousand +62.4%0.6%0.5 $4.10 9/30/202159,300 shares $237.79 thousand +9.6%N/A0.3 $4.01 9/15/202154,100 shares $209.37 thousand +29.7%0.3%0.2 $3.87 8/31/202141,700 shares $179.31 thousand +85.3%0.2%0.1 $4.30 8/13/202122,500 shares $69.75 thousand -59.4%0.1%0.1 $3.10 7/30/202155,400 shares $191.13 thousand -23.9%0.3%0.2 $3.45 7/15/202172,800 shares $264.99 thousand -47.5%0.4%0.3 $3.64 6/30/2021138,700 shares $617.22 thousand -26.9%0.8%0.6 $4.45 6/15/2021189,800 shares $1.64 million +27.7%1.1%1.9 $8.63 5/28/2021148,600 shares $1.10 million -6.8%0.9%1.6 $7.41 5/14/2021159,400 shares $1.03 million -2.8%N/A1.5 $6.47 4/30/2021164,000 shares $1.56 million -12.3%N/A1.4 $9.50 4/15/2021187,000 shares $1.78 million +8.4%N/A1.5 $9.54 3/31/2021172,500 shares $1.58 million +10.0%N/A1.2 $9.18 3/15/2021156,800 shares $1.53 million +34.5%N/A0.8 $9.74 2/26/2021116,600 shares $1.08 million +40.5%N/A0.6 $9.25 2/12/202183,000 shares $728.74 thousand -10.9%N/A0.3 $8.78 1/29/202193,100 shares $722.46 thousand +17.0%N/A0.4 $7.76 1/15/202179,600 shares $780.88 thousand -19.7%N/A0.4 $9.81 12/31/202099,100 shares $969.20 thousand +145.9%N/A0.5 $9.78 12/15/202040,300 shares $257.52 thousand +75.2%N/A0.2 $6.39 11/30/202023,000 shares $132.25 thousand +10.1%N/A0.2 $5.75 11/15/202020,900 shares $87.36 thousand -34.7%N/A0.3 $4.18 10/30/202032,000 shares $132.16 thousand +33.3%N/A0.7 $4.13 10/15/202024,000 shares $114 thousand +8.1%N/A0.4 $4.75 9/30/202022,200 shares $94.13 thousand +7.8%N/A0.4 $4.24 9/15/202020,600 shares $88.79 thousand -21.1%N/A0.4 $4.31 8/31/202026,100 shares $123.98 thousand +12.5%N/A0.4 $4.75 8/14/202023,200 shares $124.12 thousand +373.5%N/A0.3 $5.35 DMAC Short Interest - Frequently Asked Questions What is DiaMedica Therapeutics' current short interest? Short interest is the volume of DiaMedica Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 2,410,000 shares of DMAC short. Learn More on DiaMedica Therapeutics' current short interest. What is a good short interest ratio for DiaMedica Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DMAC shares currently have a short interest ratio of 10.0. Learn More on DiaMedica Therapeutics's short interest ratio. Which institutional investors are shorting DiaMedica Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of DiaMedica Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is DiaMedica Therapeutics' short interest increasing or decreasing? DiaMedica Therapeutics saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 2,410,000 shares, an increase of 13.7% from the previous total of 2,120,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does DiaMedica Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to DiaMedica Therapeutics: Urogen Pharma (15.78%), Pharming Group N.V. Sponsored ADR (0.00%), MeiraGTx Holdings PLC (4.42%), Gyre Therapeutics, Inc. (11.13%), Mind Medicine (MindMed) Inc. (15.40%), Zevra Therapeutics, Inc. (9.07%), Dianthus Therapeutics, Inc. (27.33%), Day One Biopharmaceuticals, Inc. (13.77%), atai Life Sciences N.V. (11.80%), Autolus Therapeutics PLC Sponsored ADR (5.13%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short DiaMedica Therapeutics stock? Short selling DMAC is an investing strategy that aims to generate trading profit from DiaMedica Therapeutics as its price is falling. DMAC shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against DiaMedica Therapeutics? A short squeeze for DiaMedica Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DMAC, which in turn drives the price of the stock up even further. How often is DiaMedica Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DMAC, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies Urogen Pharma Short Interest Pharming Group Short Interest MeiraGTx Short Interest Gyre Therapeutics Short Interest Mind Medicine (MindMed) Short Interest Zevra Therapeutics Short Interest Dianthus Therapeutics Short Interest Day One Biopharmaceuticals Short Interest atai Life Sciences Short Interest Autolus Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DMAC) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaMedica Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DiaMedica Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
